GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 28, 2024
Displaying entries 30701 - 30750 of 39437 in total
PDB ID UniProt ID ▲ Title Descriptor
7TFN Q2N0S6 Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664
7TXD Q2N0S6 Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly neutralizing darpin bnD.9
7UCF Q2N0S6 Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074 and BG24
8FIS Q2N0S6 Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664
8TTW Q2N0S6 Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074
7MDT Q2N0S6 BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment)
7MDU Q2N0S6 BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3
7TFO Q2N0S6 Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573
8DP1 Q2N0S6 Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab
8VFV Q2N0S6 HIV Env BG505_MD39_B16 SOSIP boosting trimer in complex with B16_d77.5 mouse Fab and RM20A3 Fab
8TOX Q2N0S6 Cryo-EM structure of BG505 Env mutant A517E in complex with antibody ACS202 Fab
8FYJ Q2N0S6 Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I)
6X97 Q2N0S6 Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment antigen binding variable domain
6X98 Q2N0S6 Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment antigen binding variable domain
8FR6 Q2N0S6 Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8G85 Q2N0S6 vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer
8G9W Q2N0S6 Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1)
8G9X Q2N0S6 Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2)
8G9Y Q2N0S6 Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3)
8GAS Q2N0S6 vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer
8G4M Q2N0S6 Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
8G4T Q2N0S6 Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP
7SQ1 Q2N0S6 BG505.MD39TS Env trimer in complex with Fab from antibody C05
7UOJ Q2N0S6 The CryoEM structure of N49-P9.6-FR3 and PGT121 Fabs in complex with BG505 SOSIP.664
7T9B Q2N0S6 ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs
8FK5 Q2N0S6 Cryo-EM Structure of PG9RSH DU011 Fab in complex with BG505 DS-SOSIP.664
8FL1 Q2N0S6 Cryo-EM Structure of PG9RSH DU025 Fab in complex with BG505 DS-SOSIP.664
8FLW Q2N0S6 Cryo-EM Structure of PGT145 DU303 Fab in complex with BG505 DS-SOSIP.664
8E1P Q2N0S6 Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs
8TJR Q2N0S6 CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO HERH-c.01 FAB
8TJS Q2N0S6 CRYO-EM STRUCTURE OF HIV-1 BG505DS-SOSIP.664 ENV TRIMER BOUND TO GPZ6-a.01 FAB
8TOP Q2N0S6 Cryo-EM structure of HIV-1 Env BG505 DS-SOSIP in complex with antibody GPZ6-b.01 targeting the fusion peptide
8TQ1 Q2N0S6 HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3
8SW4 Q2N0S6 BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
6CDE Q2N0S7 Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6MPG Q2N0S7 Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 A12V163-b.01 Light Chain, Envelope glycoprotein gp41, Envelope glycoprotein gp120, A12V163-b.01 Heavy Chain, PGT122 Heavy chain, PGT122 Light chain, VRC03 heavy chain, VRC03 Light chain
7N65 Q2N0S7 Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664
6CUF Q2N0S7 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
7LL2 Q2N0S7 Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab
7LL1 Q2N0S7 Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab
6MN7 Q2N0S7 Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment Envelope Glycoprotein gp120, Envelope Glycoprotein gp41, BF520.1 Fab variable region
6MPH Q2N0S7 Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 DF1W-a.01 heavy chain, DF1W-a.01 Light chain, Envelope glycoprotein gp120, Envelope glycoprotein gp41, PGT122 heavy chain, PGT122 Light Chain, VRC03 Heavy chain, VRC03 Light Chain
6CDI Q2N0S7 Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain
6CH7 Q2N0S7 XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain
6CH8 Q2N0S7 Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22
6CM3 Q2N0S7 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CRQ Q2N0S7 Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab
6DID Q2N0S7 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6CUE Q2N0S7 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6N1W Q2N0S7 Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024